Status:
COMPLETED
A Global Active Surveillance for Community Acquired Pneumonia
Lead Sponsor:
Pfizer
Conditions:
Community Acquired Pneumonia
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This study is an observational surveillance study to identify adults 50 years and older who present to a study healthcare facility with signs and symptoms of Community-Acquired Pneumonia.
Eligibility Criteria
Inclusion
- Adult subjects 50 years of age or older
- Subject must reside in the surveillance area
- Subjects who present to a study healthcare facility where the treating physician clinically suspects CAP
Exclusion
- Any subject who is transferred to a study healthcare facility after already being hospitalized for 48 hours or more at any other in-patient facility (such as a community hospital).
- Hospital Acquired pneumonia (ie, develops signs and symptoms of pneumonia after being hospitalized for 48 hours or more).
Key Trial Info
Start Date :
December 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
5172 Patients enrolled
Trial Details
Trial ID
NCT00929721
Start Date
December 1 2009
End Date
February 1 2012
Last Update
April 13 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Chrzanów, Poland, 32-500